{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:53:17Z","timestamp":1793832797763,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.083","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T05:25:49Z","timestamp":1532150749000},"page":"1307-1316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer"],"prefix":"10.1016","volume":"106","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Guang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.07.083_bib0005","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer, nature reviews","volume":"3","author":"Sanli","year":"2017","journal-title":"Dis. Primers"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.083_bib0010","first-page":"85","article-title":"Review of management options for localized renal cell carcinoma","volume":"1","author":"Vi Tran","year":"2017","journal-title":"Minim Invasive Surg. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.083_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics","volume":"63","author":"Siegel","year":"2013","journal-title":"CA. Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.083_bib0020","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.7314\/APJCP.2014.15.3.1459","article-title":"Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran","volume":"15","author":"Basiri","year":"2014","journal-title":"Asian Pac. J. Cancer Prev.: APJCP"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.083_bib0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.juro.2017.08.005","article-title":"Burden of multiple chronic conditions among patients with urological cancer","volume":"199","author":"Garg","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.biopha.2018.07.083_bib0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/CEOR.S135065","article-title":"Cost of illness of urothelial bladder cancer in Italy","volume":"9","author":"Gerace","year":"2017","journal-title":"Clin. Econ. Outcomes Res.: CEOR"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.083_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.urolonc.2017.12.018","article-title":"Recent developments in the treatment of advanced bladder cancer","volume":"36","author":"Godwin","year":"2018","journal-title":"Urol. Oncol."},{"issue":"22","key":"10.1016\/j.biopha.2018.07.083_bib0040","first-page":"6110","article-title":"Action of 2\u2019,2\u2019-difluorodeoxycytidine on DNA synthesis","volume":"51","author":"Huang","year":"1991","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.083_bib0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int."},{"issue":"17","key":"10.1016\/j.biopha.2018.07.083_bib0050","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.083_bib0055","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3747\/co.v18i1.695","article-title":"First- and second-line therapy for metastatic urothelial carcinoma of the bladder","volume":"18","author":"Yafi","year":"2011","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2018.07.083_bib0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1593\/neo.10458","article-title":"Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy","volume":"12","author":"Fujita","year":"2010","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.083_bib0065","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbrc.2015.07.080","article-title":"Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK","volume":"464","author":"Nakano","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.083_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: progress on research in pharmacodynamics and toxicology","volume":"155","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2018.07.083_bib0075","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/glia.20844","article-title":"Tripchlorolide protects neuronal cells from microglia-mediated beta-amyloid neurotoxicity through inhibiting NF-kappaB and JNK signaling","volume":"57","author":"Pan","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2018.07.083_bib0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-12-50","article-title":"Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy","volume":"12","author":"Wen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.083_bib0085","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.juro.2014.09.007","article-title":"Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells","volume":"193","author":"Ho","year":"2015","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.083_bib0090","first-page":"103","article-title":"Minimally invasive surgery for gallbladder cancer","volume":"1","author":"Naeem Goussous","year":"2017","journal-title":"Minimally Invasive Surg. Oncol."},{"key":"10.1016\/j.biopha.2018.07.083_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"de Sousa Cavalcante","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.083_bib0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molimm.2013.05.006","article-title":"Triptolide ameliorates ileocolonic anastomosis inflammation in IL-10 deficient mice by mechanism involving suppression of miR-155\/SHIP-1 signaling pathway","volume":"56","author":"Wu","year":"2013","journal-title":"Mol. Immunol."},{"issue":"47","key":"10.1016\/j.biopha.2018.07.083_bib0105","doi-asserted-by":"crossref","first-page":"33927","DOI":"10.1074\/jbc.M113.500983","article-title":"Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1","volume":"288","author":"Banerjee","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2018.07.083_bib0110","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/1535-7163.MCT-12-1231","article-title":"Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation","volume":"12","author":"MacKenzie","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"Pt 11","key":"10.1016\/j.biopha.2018.07.083_bib0115","first-page":"2502","article-title":"The genetic depletion or the triptolide inhibition of TFIIH in p53-deficient cells induces a JNK-dependent cell death in Drosophila","volume":"126","author":"Villicana","year":"2013","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.083_bib0120","doi-asserted-by":"crossref","first-page":"e35722","DOI":"10.1371\/journal.pone.0035722","article-title":"Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha","volume":"7","author":"Lu","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.083_bib0125","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2010.04.046","article-title":"Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways","volume":"139","author":"Mujumdar","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2018.07.083_bib0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.083_bib0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1073\/pnas.95.2.554","article-title":"Modulation of cell death by Bcl-XL through caspase interaction","volume":"95","author":"Clem","year":"1998","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.083_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/carcin\/bgx016","article-title":"Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain","volume":"38","author":"Gabellini","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2018.07.083_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcdb.2018.01.009","article-title":"Caspase-8 function, and phosphorylation, in cell migration","author":"Keller","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.083_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2018.07.083_bib0155","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.urolonc.2013.02.012","article-title":"Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3beta","volume":"32","author":"Gerhardt","year":"2014","journal-title":"Urol. Oncol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218323837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218323837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:31:54Z","timestamp":1750879914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218323837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"alternative-id":["S0753332218323837"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.083","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}